Dr. Tykocinski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-6880Fax+1 215-349-5864
Education & Training
- New York University School of MedicineClass of 1978
Certifications & Licensure
- PA State Medical License 1998 - 2024
- NJ State Medical License 2013 - 2023
- OH State Medical License 1983 - 2005
Publications & Presentations
PubMed
- 66 citationsThe gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1Douglas M. Lublin, Richard S. Lemons, M M Le Beau, V M Holers, Mark L. Tykocinski
The Journal of Experimental Medicine. 1987-06-01 - 186 citationsCloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complementM E Medof, D M Lublin, V. M. Holers, D J Ayers, Robert R. Getty
Proceedings of the National Academy of Sciences of the United States of America. 1987-04-01 - 40 citationsHuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer CellsCarmella Romeo, Matthew C. Weber, Mahsa Zarei, Danielle DeCicco, Saswati N. Chand
Molecular Cancer Research. 2016-07-01
Press Mentions
- Jefferson Names Joseph G. Cacchione, MD New CEO of Jefferson Health and Thomas Jefferson UniversityAugust 1st, 2022
- Jefferson Health Makes Strides in Treating Loss of Smell and TasteMarch 2nd, 2022
- Stephen K. Klasko Announces Retirement PlansOctober 14th, 2021
- Join now to see all
Grant Support
- Cellular Cancer VaccinesNational Cancer Institute2003–2007
- Engineering Artifical Veto CellsNational Institute Of Allergy And Infectious Diseases2002–2006
- Placental Protein 14 As A Lectin-Like ImmunomodulatorFogarty International Center2003–2005
- Placental Protein 14 As A Unique ImmunoregulatorNational Institute Of Allergy And Infectious Diseases2001–2005
- Engineering Artificial Veto CellsNational Institute Of Allergy And Infectious Diseases1999–2001
- Cellular Cancer Vaccines--Gpi Protein TransferNational Cancer Institute1999–2001
- Hematopoietic Pp14--An Antiinflammatory CytokineNational Institute Of Allergy And Infectious Diseases1999–2000
- H19 In Bladder CancerNational Cancer Institute1999
- Engineering Artificial Veto CellsNational Institute Of Allergy And Infectious Diseases1997–1998
- Cellular Cancer Vaccines--Gpi Protein TransferNational Cancer Institute1997–1998
- Core--Molecular BiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996–1998
- Hematopoietic Pp14--An Antiinflammatory CytokineNational Institute Of Allergy And Infectious Diseases1996–1998
- Protein Transfer With GPI PolypeptidesNational Institute Of Diabetes And Digestive And Kidney Diseases1996
- Cd8-Dependent ImmunoregulationNational Institute Of Allergy And Infectious Diseases1992–1996
- Human Leukemic Differentiation--Anti-Sense RNA StudiesNational Cancer Institute1988–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: